🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a robust trade exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin.

Several professionals said the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.

Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

Based on the social media company, the service has taken down violative material and banned related hashtags and query recommendations. The company stated it was committed to keeping the service safe and investing in enhancing compliance measures.

Online Marketplace Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, filled with images of slimming results, positive reviews and step-by-step guides for preparing or injecting at home.

After minutes of joining one group, a seller posted WhatsApp details, where most purchases take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.

Product Details and Pricing

Within these communities, posts show black plastic parcels with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A representative for Telegram said it regularly monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has already encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to possibly significant medical dangers”.